Literature DB >> 5649060

The specificity of antilymphocyte sera to thymic, splenic, and leukemic lymphocytes.

R Asakuma, A E Reif.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5649060

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  Proportional absorption. A method for determination of the relative specificity of antisera prepared against cells.

Authors:  A E Reif; C M Robinson
Journal:  Immunology       Date:  1975-01       Impact factor: 7.397

2.  Selected topics on antilymphocyte serum.

Authors:  T E Starzl; I Penn; L Brettschneider; K Ono; N Kashiwagi
Journal:  Fed Proc       Date:  1970 Jan-Feb

3.  Specificity of rabbit antisera against mouse leukaemias in vitro.

Authors:  A E Reif; C A Kim
Journal:  Immunology       Date:  1971-06       Impact factor: 7.397

4.  The comparative in vitro and in vivo activity of antilymphocyte serum raised by immunization with thymic, splenic, and lymph node lymphocytes.

Authors:  K Ono; P Bell; N Kashiwagi; T E Starzl
Journal:  Surgery       Date:  1969-10       Impact factor: 3.982

5.  A comparison of the responses of lymphocytes from blood, spleen, thymus and appendix of rabbits of different ages to stimulation "in vitro" with staphylococcal filtrate.

Authors:  S Knight; N R Ling
Journal:  Clin Exp Immunol       Date:  1969-06       Impact factor: 4.330

6.  Common antibody-induced redistribution on thymocytes of strain-, species- and non-species-specific antigenic determinants shared by brain and thymocytes of mice.

Authors:  H G Thiele; R Stark
Journal:  Immunology       Date:  1974-11       Impact factor: 7.397

Review 7.  Anti-lymphocytic antibody and autoimmune disease: a review.

Authors:  A M Denman
Journal:  Clin Exp Immunol       Date:  1969-09       Impact factor: 4.330

8.  Organ specificity of antithymocyte globulin.

Authors:  K P Judd; C J Bryant; J J Trentin
Journal:  Clin Exp Immunol       Date:  1971-10       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.